Related Experiment Video
Updated: Feb 7, 2026

Activation of Apoptosis by Cytoplasmic Microinjection of Cytochrome c
Published on: June 29, 2011
Cytochrome C suppresses renal accumulation and nephrotoxicity of polymyxin B
11 Department of Pharmacy, Electric Power Teaching Hospital, Capital Medical University, Beijing, China.
Abstract:
The receptor megalin plays an important role in the accumulation of polymyxin B (PMB) in renal cells in vitro. This study aimed to examine the effects of cytochrome c (cyto c), a typical megalin ligand, on renal accumulation and nephrotoxicity of PMB in vivo. Thirty Sprague-Dawley rats were randomly divided into the vehicle control group, PMB group, PMB + cyto c 50, 100, or 200 mg/kg group, respectively, and were treated with intravenous cyto c 30 min before the administration of PMB 4.0 mg/kg once a day for consecutive 5 days. On the 4th day after administration, 24 h urine was collected to determine N-acetyl-β-D-glucosaminidase excretion. Six hours after the last injection on the 5th day, kidneys were harvested to assay PMB concentration and observe pathological alterations, and blood samples were collected to assay serum creatinine (SCr), blood urea nitrogen (BUN), and blood β2-microglobulin (β2-MG) levels. Cyto c 50, 100, and 200 mg/kg decreased the accumulation of PMB in the kidney by 18.5%, 39.1% ( p < 0.01), and 36.8% ( p < 0.01), respectively, and reduced 24 h N-acetyl-β-D- glucosaminidase excretion by 22.5% ( p < 0.05), 40.4% ( p < 0.01), and 40.4% ( p < 0.01), respectively. Kidney pathological damage induced by PMB was markedly reduced by cyto c 100 mg/kg and 200 mg/kg. However, there were no significant differences in SCr, BUN, and blood β2-MG levels among the groups. These results indicated that cyto c may inhibit the renal accumulation and nephrotoxicity of PMB in a rat model, further proving the role of megalin in the accumulation of PMB.
Insights
Cytochrome c administration reduced kidney accumulation and toxicity of polymyxin B in rats. This suggests cytochrome c may protect against polymyxin B-induced kidney damage by interacting with the megalin receptor.
Area of Science:
- Nephrology
- Pharmacology
- Cell Biology
Background:
- The receptor megalin is implicated in the renal accumulation of polymyxin B (PMB) in vitro.
- Understanding PMB's in vivo renal handling and toxicity is crucial for its clinical application.
Purpose of the Study:
- To investigate the effect of cytochrome c (cyto c), a known megalin ligand, on the renal accumulation and nephrotoxicity of PMB in a rat model.
- To further elucidate the role of megalin in PMB renal uptake.
Main Methods:
- Thirty Sprague-Dawley rats were administered PMB intravenously, with or without varying doses of cyto c.
- Renal PMB concentration, N-acetyl-β-D-glucosaminidase excretion, and kidney pathology were assessed.
- Serum creatinine, blood urea nitrogen, and blood β2-microglobulin levels were measured.
Main Results:
- Cyto c significantly decreased PMB accumulation in the kidneys in a dose-dependent manner (up to 39.1%).
- Cyto c administration reduced N-acetyl-β-D-glucosaminidase excretion and ameliorated kidney pathological damage induced by PMB.
- No significant changes were observed in serum creatinine, BUN, or blood β2-microglobulin levels.
Conclusions:
- Cytochrome c demonstrates potential in inhibiting renal accumulation and nephrotoxicity of PMB in vivo.
- These findings support the role of the megalin receptor in mediating PMB renal uptake and toxicity.
Related Concept Videos
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Renal Clearance
Renal clearance refers to the volume of plasma cleared of a specific substance, such as creatinine, per unit of time. To measure clearance, urine samples are collected over a 24-hour period during each bladder voiding, followed by a single blood sample at the...
Renal Drug Clearance: Comparison Between Renal Excretion Methods
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

